A rare case of primary mesenteric gastrointestinal stromal tumor with metastasis to the cervix uteri

被引：10

作者：

Gupta N. ^{[1
]}

Mittal S. ^{[1
]}

Lal N. ^{[1
]}

Misra R. ^{[2
]}

Kumar L. ^{[3
]}

Bhalla S. ^{[4
]}

机构：

[1] Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi

[2] Department of Obstetrics and Gynaecology, Moolcahnd Khairati Hospital, New Delhi

[3] Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi

[4] Department of Pathology, Sir Gangaram Hospital, New Delhi

来源：

World Journal of Surgical Oncology | / 5卷 / 1期

关键词：

Imatinib; Gastrointestinal Stromal Tumor; Adnexal Mass; Pediatric GISTs; Infracolic Omentectomy;

D O I：

10.1186/1477-7819-5-137

中图分类号：

学科分类号：

摘要：

Background: Gastrointestinal stromal tumors are CD117 (C Kit) positive mesenchymal neoplasms, that may arise anywhere in the gastrointestinal tract. Their current therapy is imatinib mesylate before or after surgery. Case presentation: We describe a case of 17-year-old female with metastasis to the cervix uteri of a primary mesenteric gastrointestinal tumor. Conclusion: Surgery remains the mainstay of known curative treatment. The manifestations of GIST are not restricted to the typical locations within the bowel; may have very unusual metastatic sites or infiltrations per continuitatem. © 2007 Gupta et al; licensee BioMed Central Ltd.

引用

共 11 条

[1]

Joensuu H., Kindblom L.G., Gastrointestinal stromal tumors - A review, Acta Orthop Scand Suppl, 75, 311, pp. 62-71, (2004)

[2]

Miettinen M., Lasota J., Gastrointestinal stromal tumors: Definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis, Virchows Arch, 438, pp. 1-12, (2001)

[3]

Prakash S., Sarran L., Socci N., DeMatteo R.P., Eisenstat J., Greco A.M., Maki R.G., Wexler L.H., LaQuaglia M.P., Besmer P., Antonescu C.R., Gastrointestinal Stromal Tumors in Children and Young Adults: A Clinicopathologic, Molecular, and Genomic Study of 15 Cases and Review of the Literature, J Pediatr Hematol Oncol, 13, pp. 179-187, (2005)

[4]

Hirota S., Isozaki K., Moriyama Y., Hashimoto K., Nishida T., Ishiguro S., Kawano K., Hanada M., Kurata A., Takeda M., Muhammad Tunio G., Matsuzawa Y., Kanakura Y., Shinomura Y., Kitamura Y., Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors, Science, 279, pp. 577-580, (1998)

[5]

Haller F., Detken S., Schulten H.J., Happel N., Gunawan B., Kuhlgatz J., Fuzesi L., Surgical management after neoadjuvant imatinib therapy in gastrointestinal stromal tumours (GISTs) with respect to imatinib resistance caused by secondary KIT mutations, Ann Surg Oncol, 14, pp. 526-532, (2007)

[6]

Demetri G.D., von Mehren M., Blanke C.D., Van den Abbeele A.D., Eisenberg B., Roberts P.J., Heinrich M.C., Tuveson D.A., Singer S., Janicek M., Fletcher J.A., Silverman S.G., Silberman S.L., Capdeville R., Kiese B., Peng B., Dimitrijevic S., Druker B.J., Corless C., Fletcher C.D., Joensuu H., Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors, N Engl J Med, 347, pp. 472-480, (2002)

[7]

Therasse P., Arbuck S.G., Eisenhauer E.A., Wanders J., Kaplan R.S., Rubinstein L., Verweij J., Van Glabbeke M., van Oosterom A.T., Christian M.C., Gwyther S.G., New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada, J Natl Cancer Inst, 92, pp. 205-216, (2000)

[8]

Zighelboim I., Henao G., Kunda A., Gutierrez C., Edwards C., Gastrointestinal stromal tumor presenting as a pelvic mass, Gynecol Oncol, 91, pp. 630-635, (2003)

[9]

Carlomagno G., Beneduce P., A gastrointestinal stromal tumor (GIST) masquerading as an ovarian mass, World J Surg Oncol, 2, (2004)

[10]

Belics Z., Csapo Z., Szabo I., Papay J., Szabo J., Papp Z., Large gastrointestinal stromal tumor presenting as an ovarian tumor. A case report, J Reprod Med, 48, pp. 655-658, (2003)

← 1 2 →